Your search returned over 250 studies. The top 250 studies are being displayed. Please use additional keywords or decrease the search distance. Get alerts for new studies
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
348 Locations available
- Treatment of Patients With Advanced Renal Cancer With a Radio-labeled Antibody, Yttrium-90 Conjugated Chimeric G250
Conditions: Renal Cell Carcinoma - Kidney Neoplasm - Renal Cancer - Kidney Cancer
1 Location available
- Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women
Conditions: DCIS - Early Invasive Breast Cancer
1 Location available
- Storage of Bile From Routine Procedures to Study Risk Factors
Conditions: Gallbladder Cancer - Cholangiocarcinoma - Biliary Tract Cancer
1 Location available
- Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate
Conditions: Atypical Endometrial Hyperplasia - Endometrial Carcinoma
2 Locations available
- Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma
Conditions: Carcinoma, Giant Cell - Carcinoma, Non-Small-Cell Lung - Lung Cancer
1 Location available
- Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry
Conditions: Barrett's Esophagus - Gastroesophageal Reflux Disease - Esophageal Adenocarcinoma
1 Location available
- Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian Cancer
Conditions: Adenocarcinoma of the Ovary
3 Locations available
- Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Pat
Conditions: Carcinoma, Squamous Cell
1 Location available
- Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Conditions: Lung Neoplasm - Carcinoma Non-small Cell Lung Cancer Stage IIIA - Carcinoma Non-small Cell Lung Cancer Stage IIIB - Carcinoma Non-small Cell Lung Cancer Stage IV
50 Locations available
- TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC)
Conditions: Hepatocellular Carcinoma
1 Location available
- Induction Therapy-Docetaxel, Cisplatin and Fluorouracil in Untreated Advanced Squamous Cell or Undifferentiated Carcinoma of the Paranasal Sinuses
Conditions: Paranasal Sinuses - Squamous Cell Carcinoma
1 Location available
- Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors
Conditions: Cancer - Non-Small Cell Lung Cancer - Endometrial Carcinoma - Ovarian Carcinoma
3 Locations available
- Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Can
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer
21 Locations available
- Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocelluar Carcinoma
Conditions: Liver Cancer - Hepatitis B - Hepatitis C - Hepatobiliary Cancers Liver - Hepatobiliary Cancers
1 Location available
- Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma
Conditions: Urothelial Cancer - Muscle-invasive Urothelial Carcinoma
4 Locations available
- Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery
Conditions: Adrenocortical Carcinoma
18 Locations available
- Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin for Non-Small Cell Lung Cancer With KRAS or EGFR Activation
Conditions: Carcinoma, Non-small Cell Lung
5 Locations available
- Effect of Pharmacogenomics Differences in Phase I and II Metabolism of Tamoxifen on Efficacy and Toxicity
Conditions: Breast Cancer - Ductal Carcinoma in Situ
1 Location available
- Cholecalciferol Supplement in Treating Patients With Localized Prostate Cancer Undergoing Observation
Conditions: Adenocarcinoma of the Prostate - Stage I Prostate Cancer - Stage II Prostate Cancer - Stage III Prostate Cancer - Stage IV Prostate Cancer
1 Location available
- A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations
Conditions: Mouth Cancer - Lip Cancer - Throat Cancer - Lip Neoplasms - Head and Neck Cancers
1 Location available
- Dose Escalation Study for Primary Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular
1 Location available
- Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ
Conditions: Breast Cancer
1 Location available
- Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Conditions: Stage III Squamous Cell Carcinoma of the Hypopharynx - Stage III Squamous Cell Carcinoma of the Larynx - Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity - Stage III Squamous Cell Carcinoma of the Nasopharynx - Stage III Squamous Cell Carcinom
9 Locations available
- Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer
Conditions: Breast Cancer
4 Locations available
- Dendritic Cell Vaccine for Head and Neck Cancer
Conditions: Squamous Cell Carcinoma of Head and Neck
1 Location available
- Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck
Conditions: Squamous Cell Carcinoma of the Head and Neck - Basaloid Squamous Cell Carcinoma - Undifferentiated Carcinoma - Adenosquamous Cell Carcinoma
1 Location available
- Combination Chemotherapy, Intensity-Modulated Radiation Therapy, and Surgery in Treating Patients With Localized Pancreatic Cancer That Can Be Removed
Conditions: Adenocarcinoma of the Pancreas - Stage IA Pancreatic Cancer - Stage IB Pancreatic Cancer - Stage IIA Pancreatic Cancer - Stage IIB Pancreatic Cancer
1 Location available
- Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
Conditions: Hepatocellular Carcinoma
6 Locations available
- Sexual Behavior in Head and Neck Cancer Patients
Conditions: Oropharyngeal Cancer - Head and Neck Cancer - Squamous Cell Carcinoma
1 Location available
- Anatomical Relationship of Level IB Lymph Nodes to the Submandibular Gland in Cancer Patients
Conditions: Carcinoma
1 Location available
- Permission to Collect Blood Over Time for Research
Conditions: Pancreatic Cancer - Gastrointestinal Neoplasms - Colon Rectal Cancer Adenocarcinoma - Esophageal Cancer - Gall Bladder Cancer - Gastric (Stomach) Cancer - Gastrooesophageal Cancer - Gastrointestinal Stromal Tumor (GIST) - Hepatobiliary Neoplasm - Liver Ca
1 Location available
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
793 Locations available
- A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ova
Conditions: Cancer - Carcinoma - Fallopian Tube Cancer - Gynecological Malignancies - Metastases - Oncology - Ovarian Cancer - Solid Tumors - Tumors
8 Locations available
- Mitotane With or Without IMC-A12 in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery
Conditions: Adrenocortical Carcinoma
4 Locations available
- Bacillus Calmette-Guerin Followed by Sunitinib for the Treatment of High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma
Conditions: Urinary Tract Urothelial Carcinoma
1 Location available
- Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194
Conditions: Breast Cancer
1 Location available
- Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma - Renal Cancer
2 Locations available
- A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®
Conditions: Liver Tumors - Hepatocellular Carcinoma - Hepatoma - Neoplasms
1 Location available
- Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma
Conditions: Gastric Cancer - Adenocarcinoma
26 Locations available
- Genetic Study of Patients With Inherited Urologic Malignancies
Conditions: Birt Hogg Dube Syndrome - Hereditary Papillary Renal Cell Carcinoma - Kidney Cancer - Multiple Endocrine Neoplasia - Von Hippel-Lindau Syndrome
1 Location available
- Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
Conditions: Prostate Cancer
15 Locations available
- Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer
Conditions: Colorectal Neoplasms - Colorectal Cancer - Colorectal Tumor - COlorectal Carcinoma
1 Location available
- Lapatinib in Treating Women With Ductal Carcinoma In Situ of the Breast
Conditions: Breast Cancer
5 Locations available
- Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma
Conditions: Esophageal Adenocarcinoma - Gastric Adenocarcinoma
2 Locations available
- Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma
Conditions: Liver Cancer
3 Locations available
- Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery
Conditions: Breast Cancer
2 Locations available
- Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
Conditions: Hereditary Clear Cell Renal Cell Carcinoma - Kidney Cancer
1 Location available
- Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma
Conditions: Stomach Cancer - Gastric (Stomach) Cancer - Gastro-Esophageal(GE) Junction Cancer - Gastrointestinal Stromal Tumor (GIST)
1 Location available
- PF-00299804 As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung
Conditions: Carcinoma, Non-small Cell
6 Locations available
- A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma
Conditions: Nasopharyngeal Carcinoma
2 Locations available
- Transarterial Chemoembolization Versus Proton Beam Radiotherapy for the Treatment of Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular
1 Location available
- A Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract
Conditions: Head and Neck Squamous Cell Carcinoma
1 Location available
- A Pilot for a Case-Control Study of Esophageal Squamous Cell Carcinoma in Western Kenya
Conditions: Esophageal Neoplasms
1 Location available
- A Clinical Study of GP73 as a Hepatocellular Carcinoma (HCC) Tumor Mark
Conditions: Hepatocellular Carcinoma
1 Location available
- A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
Conditions: Stomach Neoplasms - Esophageal Neoplasms
3 Locations available
- Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients
Conditions: Metastatic Renal Cell Carcinoma
1 Location available
- Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer
Conditions: Renal Cell Carcinoma
1 Location available
- A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancie
Conditions: Renal Cell Carcinoma - Breast Cancer - Colon Cancer - Lung Cancer - Non-Hodgkin Lymphoma
3 Locations available
- Ixabepilone to Treat Cervical Cancer
Conditions: Cervical Carcinoma - Cervical Adenocarcinoma - Cervical Adenosquamous Carcinoma - Cervical Carcinoma, Non-SquamousType
1 Location available
- Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastro
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer - Gastric Cancer
204 Locations available
- Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetax
Conditions: Non-small Cell Lung Cancer
4 Locations available
- Trial of Adjuvant Sutent for Patients With High Risk Urothelial Carcinoma After Neoadjuvant Chemotherapy and Cystectomy
Conditions: Urothelial Carcinoma - Bladder Cancer
1 Location available
- Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma
Conditions: Testicular Cancer - Germ Cell Neoplasm
1 Location available
- Transplant Patient Registry of Liver, Kidney and/or Pancreas
Conditions: Hepatitis B - Hepatitis C - Liver Cirrhosis - Hepatocellular Carcinoma - Polycystic Kidney Diseases
1 Location available
- Registry Study of Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma Patients
Conditions: Cholangiocarcinoma
1 Location available
- A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
Conditions: Metastatic Breast Cancer - Advanced Breast Cancer - Gastrointestinal Stromal Tumor - Hepatocellular Carcinoma - Metastasizing Breast Cancer (F) - Metastatic Castration-Resistant Prostrate Cancer - Metastatic Renal Cell Cancer - Non Small Cell Lung Cancer
2 Locations available
- Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma
Conditions: Esophageal Neoplasms - Stomach Neoplasms - Neoplasm Metastasis
2 Locations available
- Multipeptide Vaccine for Advanced Breast Cancer
Conditions: Breast Neoplasm - Breast Cancer - Cancer of the Breast - Carcinoma, Ductal
1 Location available
- Endoscopic Mucosal Resection (EMR) in Barrett's Esophagus
Conditions: Barrett's Esophagus - Early Esophageal Adenocarcinoma
1 Location available
- The Effect of Ablation Therapy on Barrett's Esophagus
Conditions: Barrett's Esophagus - Early Esophageal Adenocarcinoma
1 Location available
- Mammosite Breast Brachytherapy Optimization in the Treatment of Breast Carcinoma
Conditions: Breast Neoplasms
1 Location available
- Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck
Conditions: Head and Neck Cancer
1 Location available
- FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer
Conditions: Colorectal Cancer - Colorectal Carcinoma - Liver Metastases
34 Locations available
- SBRT + TACE for Primary Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma
4 Locations available
- Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma - Kidney Cancer
3 Locations available
- Capecitabine, Gemcitabine, and Radiation Therapy in Treating Patients With Cholangiocarcinoma of the Gallbladder or Bile Duct
Conditions: Extrahepatic Bile Duct Cancer - Gallbladder Cancer
236 Locations available
- Photon/Proton Beam Radiation Therapy for Carcinoma of the Nasopharynx
Conditions: Carcinoma of the Nasopharynx
1 Location available
- Genetic Susceptibility to Kidney Cancer
Conditions: Renal Cell Carcinoma
1 Location available
- LC Drug Eluting Bead for Treatment of Liver Cancer Which Cannot be Surgically Removed
Conditions: Hepatocellular Carcinoma
1 Location available
- Phase II Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC)
Conditions: Head and Neck Cancer - Cancer of Nasopharynx
1 Location available
- Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease
Conditions: Breast Cancer
3 Locations available
- Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma
Conditions: Head and Neck Squamous Cell Carcinoma
7 Locations available
- A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area
Conditions: Carcinoma, Hepatocellular - Liver Cirrhosis, Alcoholic - Hepatitis, Alcoholic - Hepatitis, Chronic - Hepatitis, Viral, Human
3 Locations available
- Metastasectomy Study in Renal Cell Carcinoma (RCC)
Conditions: Kidney Cancer
1 Location available
- Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC)
Conditions: Primary Sclerosing Cholangitis - Trisomy 7 - Cholangiocarcinoma - Chemoprevention
1 Location available
- DNA Chip Based Prognosis of Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
2 Locations available
- A Safety Study of LBH589 (Panobinostat) and RAD001 (Everolimus) to Stabilize Kidney Cancer
Conditions: Renal Cell Carcinoma - Metastatic Renal Cell Carcinoma
2 Locations available
- Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma
Conditions: Cancer of the Cervix
1 Location available
- Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
Conditions: Liver Cancer
1 Location available
- Data Collection for Patients With Low Grade Ovarian Carcinoma
Conditions: Ovarian Cancer - Peritoneum Tumors
1 Location available
- Brachytherapy for Prostatic Carcinoma Patients
Conditions: Prostate Cancer
1 Location available
- Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo.
Conditions: Basal Cell Carcinoma - Melanoma - Squamous Cell Carcinoma - Non-Malignant Skin Disorders
1 Location available
- A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer
Conditions: Hedgehog Pathway - Smoothened - Basal Cell Carcinoma (BCC) - Basal Cell Nevoid Syndrome (BCNS)
2 Locations available
- A Phase 1b Study of MDX-1106 in Subjects With Advanced or Recurrent Malignancies
Conditions: Metastatic Castration-resistant Prostrate Cancer (mCRPC) - Renal Cell Carcinoma (RCC) - Metastatic Melanoma (MEL) - Non-small Cell Lung Cancer (NSCLC)
10 Locations available
- Levonorgestrel Intrauterine Device (IUD) to Treat Complex Atypical Hyperplasia (CAH) and Grade 1 Endometrioid Endometrial Carcinoma (G1EEC)
Conditions: Hyperplasia - Endometrial Cancer
3 Locations available
- Photon/Proton Beam Radiation Therapy for Carcinoma of the Skin of the Head and Neck
Conditions: Head and Neck Cancer
1 Location available
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
97 Locations available
- Neo-Adjuvant FOLFOX for Rectal Carcinoma
Conditions: Rectal Neoplasms
2 Locations available
- Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer
Conditions: Carcinoma, Renal Cell
1 Location available
- Study of Radiation (RT) Concurrent With Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (SCC)
Conditions: Head and Neck Cancer
2 Locations available
- Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer
Conditions: Prostate Cancer - Adenocarcinoma
4 Locations available
- A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer
Conditions: Small Cell Lung Carcinoma
2 Locations available
- Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes
Conditions: Nasopharyngeal Carcinoma
3 Locations available
- Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung Cancer
Conditions: Carcinoma, Non Small Cell Lung
1 Location available
- Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duoden
Conditions: Extrahepatic Bile Duct Cancer - Gallbladder Cancer - Liver Cancer - Pancreatic Cancer - Periampullary Adenocarcinoma - Small Intestine Cancer
2 Locations available
- Letrozole as a Treatment of Endometrial Cancer
Conditions: Endometrial Carcinoma
2 Locations available
- Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma - Liver Cancer
1 Location available
- Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma
2 Locations available
- Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma of the Head and Neck
1 Location available
- Fluorine F 18 EF5 Positron Emission Tomography in Assessing Hypoxia in Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Head or
Conditions: Squamous Cell Carcinoma
1 Location available
- Dose Dense MVAC for Muscle Invasive Bladder Cancer
Conditions: Muscle Invasive Bladder Cancer - High Risk Urothelial Carcinoma of the Upper Urinary Tracts
2 Locations available
- Observational Study of Swallowing Function After Treatment of Advanced Laryngeal Cancer
Conditions: Squamous Cell Carcinoma - Laryngeal Cancer
1 Location available
- MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma of the Head and Neck
1 Location available
- Metabolomic Analysis of Lung Cancer
Conditions: Carcinoma, Non-Small Cell Lung - Carcinoma, Small Cell Lung
1 Location available
- Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
Conditions: Adrenocortical Carcinoma
68 Locations available
- Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
Conditions: Carcinomas (Including Squamous Cell and Adenocarcinoma) - Neoplasms
1 Location available
- Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-Naive Patients With Advanced/Metastatic Bladder Carcinoma
Conditions: Bladder Cancer
1 Location available
- Identification of Key Blood Molecular Markers for Immunotherapy
Conditions: Squamous Cell Carcinoma - Adenocarcinoma - Neoplasms
1 Location available
- RAD001 in Advanced Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma
3 Locations available
- Trial of Beads Versus Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma - Liver Cancer - Hepatoma
1 Location available
- A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer
Conditions: Carcinoma, Squamous Cell
1 Location available
- Proton Therapy for Resectable Carcinoma of the Pancreas
Conditions: Pancreatic Cancer
1 Location available
- Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate
Conditions: Prostate Cancer
1 Location available
- Everolimus(RAD001) For Advanced Renal Cell Carcinoma(RCC)Before Kidney Removal
Conditions: Kidney Cancer
2 Locations available
- Aberant Gene Expression Prostate Carcinoma
Conditions: Prostate Cancer
1 Location available
- Perioperative Treatment With Zoledronic Acid in Patients With Resectable Pancreas Cancer
Conditions: Adenocarcinoma
1 Location available
- Safety and Efficacy of Radiation/Cetuximab Plus EGFR Antisense DNA for Head and Neck Squamous Cell Carcinoma
Conditions: Carcinoma, Squamous Cell
1 Location available
- TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma - Liver Cancer - Liver Neoplasm - Primary Liver Cancer
1 Location available
- Follow Up Protocol for Subjects Previously Enrolled in NCI Surgery Branch Studies
Conditions: Melanoma - Adenocarcinoma - Carcinoma NOS - Neuroendocrine Tumors
1 Location available
- A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers
Conditions: Small Cell Lung Carcinoma - Malignant Epithelial Neoplasms
1 Location available
- Preoperative Treatment With Cetuximab and/or IMC-A12
Conditions: Head and Neck Squamous Cell Carcinoma
1 Location available
- Combination Chemotherapy With or Without GDC-0449 in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Gastric Cancer
17 Locations available
- A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
5 Locations available
- A Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the Lung
Conditions: Carcinoma
8 Locations available
- Safety Study of PLX108-01 in Patients With Solid Tumors
Conditions: Solid Tumors - Mucoepidermal Carcinoma (MEC) of the Salivary Gland - Pigmented Villo-nodular Synovitis (PVNS) - Gastrointestinal Stromal Tumors (GIST) - Anaplastic Thyroid Carcinoma (ATC) - Solid Tumors With Documented Malignant Pleural or Peritoneal Effu
10 Locations available
- BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma
24 Locations available
- MLN8237 in Adults With Nonhematological Malignancies, Followed by MLN8237 in Lung, Breast, Head and Neck or Gastroesophageal Malignancies
Conditions: Advanced Nonhematological Malignancies - Non-Small Cell Lung Cancer - Small Cell Lung Cancer - Metastatic Breast Cancer - Head and Neck Squamous Cell Carcinoma - Gastroesophageal Adenocarcinoma
3 Locations available
- Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer
Conditions: Adrenocortical Carcinoma
1 Location available
- Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis
Conditions: Peritoneal Cancer
1 Location available
- Safety Study of Modified Vaccinia Virus to Cancer
Conditions: Melanoma - Breast Cancer - Head and Neck Squamous Cell Cancer - Liver Cancer - Colorectal Cancer - Pancreatic Adenocarcinoma
1 Location available
- Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RADOO1
Conditions: Kidney Neoplasms - Kidney (Renal Cell) Cancer
1 Location available
- Trial of Second Generation Designer T Cells in Colorectal Carcinoma
Conditions: Colorectal Cancer
1 Location available
- Phase I Trial of TGFB2-Antisense-GMCSF Gene Modified Autologous Tumor Cell (TAG) Vaccine for Advanced Cancer
Conditions: Advanced Metastatic Carcinoma
1 Location available
- Four Doses of MAGE Vaccine for Patients With Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma - Head and Neck Cancer
1 Location available
- Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases
Conditions: Liver Cancer - Metastatic Cancer
1 Location available
- Microwave Ablation of Resectable Liver Tumors
Conditions: Hepatocellular Carcinoma - Liver Cancer
1 Location available
- Computed Tomography (CT) Perfusion Imaging of Lung Cancer
Conditions: Carcinoma, Non Small Cell Lung
4 Locations available
- Photodynamic Therapy (PDT) Trial for Palliation of Cholangiocarcinoma
Conditions: Cholangiocarcinoma
1 Location available
- The Pancreatic Adenocarcinoma Gene Environment Risk Study - A Study of Patients at Risk or Having Pancreatic Disease
Conditions: Pancreatic Cancer
3 Locations available
- Image-Guided Adaptive Conformal Photon Versus Proton Therapy
Conditions: Non-Small-Cell Lung Carcinoma
2 Locations available
- Sirolimus and Pemetrexed to Treat Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
1 Location available
- A Study to Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advanced Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma
2 Locations available
- Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma
Conditions: Head And Neck Cancer
1 Location available
- Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma
Conditions: Liver Cancer
3 Locations available
- A Study of REOLYSIN® in Combination With Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma
Conditions: Metastatic Pancreatic Adenocarcinoma
2 Locations available
- A Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile Ducts
Conditions: Cholangiocarcinoma
3 Locations available
- Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Conditions: Refractory Head and Neck Cancer, Squamous Cell Carcinoma of the Skin, Carcinoma of the Breast, and Malignant Melanoma
4 Locations available
- Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck
Conditions: Head and Neck Cancer - Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - R
1 Location available
- Stereotactic Radiation Therapy, Nelfinavir Mesylate, Gemcitabine Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Locally
Conditions: Adenocarcinoma of the Pancreas - Pancreatic Cancer - Stage III Pancreatic Cancer
1 Location available
- Velcade and Sorafenib in Unresected or Metastatic Renal Cell Carcinoma
Conditions: Metastatic Renal Cell Carcinoma
3 Locations available
- Re-irradiation With Fractionated Stereotactic Radiosurgery Plus Cetuximab in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma of the Head and Neck
1 Location available
- Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
1 Location available
- Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer
Conditions: Renal Cell Carcinoma - Graft-Versus-Host Disease - Engraftment Syndrome
2 Locations available
- Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma
Conditions: Biliary Cancer - Cholangiocarcinoma
1 Location available
- A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer
Conditions: Cholangiocarcinoma - Biliary Tract Cancer - Gallbladder Cancer
1 Location available
- Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)
Conditions: Hepatocellular Carcinoma
1 Location available
- A Study of Erlotinib Plus Radiotherapy (RT) for Patients With Advanced or Inoperable Non-Small-Cell Lung Cancer
Conditions: Carcinoma, Non-small-cell Lung
2 Locations available
- Magnetic Resonance Imaging (MRI) in the Assessment of Head and Neck Squamous Cell Carcinoma (HNSCC) Response
Conditions: Head and Neck Cancer
1 Location available
- Trial of LBH589 in Metastatic Thyroid Cancer
Conditions: Thyroid Carcinoma
2 Locations available
- A Phase I Study of Intravenous Recombinant Human IL-15 in Adults With Refractory Metastatic Malignant Melanoma and Metastatic Renal Cell Cancer
Conditions: Melanoma - Carcinoma, Renal Cell
1 Location available
- Abiraterone Acetate, Prednisone, and Leuprolide Acetate or Goserelin Before and During Radiation Therapy in Treating Patients With Localized or Locall
Conditions: Adenocarcinoma of the Prostate - Stage II Prostate Cancer - Stage III Prostate Cancer - Stage IV Prostate Cancer
2 Locations available
- Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial)
Conditions: Carcinoma, Intraductal, Noninfiltrating - DCIS - Ductal Carcinoma In Situ
4 Locations available
- Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer
Conditions: Renal Cell Carcinoma - Stage III Renal Cell Cancer - Stage IV Renal Cell Cancer
1 Location available
- PD 0332991 in Treating Patients With Refractory Solid Tumors
Conditions: Adult Solid Tumor - Adenocarcinoma of the Colon - Adenocarcinoma of the Rectum - Adult Central Nervous System Germ Cell Tumor - Adult Teratoma - Benign Teratoma - Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - Famili
1 Location available
- Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
Conditions: Stomach Cancer - Gastro-Esophageal(GE) Junction Cancer - Gastric (Stomach) Cancer - Esophageal Cancer - Gastrointestinal Stromal Tumor (GIST)
1 Location available
- Phase II Study of RAD001 Head and Neck Cancer
Conditions: Squamous Cell Carcinoma of the Head and Neck
1 Location available
- A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Conditions: Ovarian Cancer - Non Small Cell Lung Cancer - Prostate Cancer - Colorectal Cancer - Gastric Cancer - Esophageal Cancer - Cancer of Head and Neck
23 Locations available
- Dalteparin in Combination With Sunitinib in Patients With Metastatic Kidney Cancer
Conditions: Renal Cell Carcinoma
2 Locations available
- Docetaxel And Cisplatin With or Without Erlotinib For Metastatic Or Recurrent Squamous Cell Carcinoma Of Head And Neck
Conditions: Head and Neck Cancer - Squamous Cell Carcinoma of the Head and Neck
1 Location available
- Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas
Conditions: Metastatic Pancreatic Cancer
2 Locations available
- MLN8237 in Patients With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breas
Conditions: Ovarian Carcinoma - Fallopian Tube Cancer - Peritoneal Cancer - Breast Carcinoma
2 Locations available
- Phase III of Unilateral Neck Irradiation With Amifostine in Patients With SCC of the Head and Neck
Conditions: Squamous Cell Carcinoma of the Head and Neck
1 Location available
- Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
Conditions: Gastroesophageal Junction Adenocarcinoma - Gastric Cancer
15 Locations available
- Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI
Conditions: Kidney Neoplasms - Carcinoma, Renal Cell - Kidney (Renal Cell) Cancer
1 Location available
- Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI
Conditions: Hepatocellular Carcinoma
1 Location available
- Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma - Neoplasm Metastases
3 Locations available
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
398 Locations available
- Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ
Conditions: Breast Cancer - Lobular Carcinoma - Invasive Breast Cancer
1 Location available
- Improving Therapeutic Outcomes in the Tongue Carcinoma Patient: Assessment of Adaptation Using Functional Magnetic Resonance Imaging and Diffusion Ten
Conditions: Tongue Carcinoma
1 Location available
- Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma or Ependymoma
Conditions: Brain and Central Nervous System Tumors
4 Locations available
- Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium
Conditions: Bladder Cancer
1 Location available
- Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast
Conditions: Breast Cancer
1 Location available
- Sentinel Lymph Node (SLN) Biopsy for Sebaceous Gland Carcinoma of Eyelid
Conditions: Eye Cancer
1 Location available
- A Study of IMC-A12 in Combination With Sorafenib in Patients With Advanced Cancer of the Liver
Conditions: Hepatocellular Carcinoma
7 Locations available
- Paclitaxel, Carboplatin and Vorinostat for the Treatment of Advanced Stage Ovarian Carcinoma
Conditions: Ovarian Neoplasms
1 Location available
- Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma
Conditions: Thymic Carcinoma
2 Locations available
- Lung Cancer Mutation Consortium Protocol
Conditions: Stage IIIB/IV Adenocarcinoma
1 Location available
- Electronic Brachytherapy for the Treatment of NMSC
Conditions: Basal Cell Carcinoma - Squamous Cell Carcinoma
5 Locations available
- Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine
Conditions: Pancreatic Cancer - Ductal Adrenocarcinoma - Exocrine Pancreatic Cancer
16 Locations available
- Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular
Conditions: Carcinoma
6 Locations available
- Study of Pazopanib and Doxil in Patients With Advanced Relapsed Platinum-Sensitive or Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Carcinoma
4 Locations available
- Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.
Conditions: Liver Neoplasms - Adenoma - Carcinoma - Liver Abscess
3 Locations available
- Digital Breast Tomosynthesis Versus Contrast Enhanced Magnetic Resonance Imaging (MRI) for Breast Cancer Staging
Conditions: Ductal Carcinoma In Situ - Invasive Breast Cancer
1 Location available
- Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors
Conditions: Pancreatic Cancer - Liver Cancer - Lung Cancer - Lung Cancer Non-Small Cell Cancer (NSCLC) - Lung Cancer Small Cell Lung Cancer (SCLC) - Hepatobiliary Cancers - Hepatobiliary Cancers Liver - Hepatobiliary Cancers Hepatocellular Carcinoma (Hepatoma) - Hepa
1 Location available
- Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC
Conditions: Hepatocellular Carcinoma
10 Locations available
- Vaccine Therapy in Treating Patients With Ductal Carcinoma In Situ of the Breast
Conditions: Breast Cancer
1 Location available
- An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The
Conditions: Carcinoma, Non-Small-Cell Lung
13 Locations available
- An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gen
Conditions: Carcinoma, Non-Small-Cell Lung
4 Locations available
- Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
Conditions: Carcinoma of Unknown Primary
176 Locations available
- Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-
Conditions: Renal Cell Carcinoma - Non-hodgkin's Lymphoma
5 Locations available
- Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone
Conditions: Adenocarcinoma - Her2+ - Advanced Metastatic Breast Cancer - Metastatic ErbB2 - Invasive Breast Cancer - Advanced Breast Cancer - Cancer - ErbB2+
19 Locations available
- Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer
Conditions: Pancreatic Cancer - Periampullary Adenocarcinoma
1 Location available
- Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Gastric Cancer
24 Locations available
- Cure Rates of Superficial Basal Cell Carcinom (BCC) Following 1 Versus 3 Cycles of Electrodessication and Curettage (ED&C)
Conditions: Superficial Basal Cell Carcinoma
1 Location available
- A Study of Cisplatin + Pemetrexed + Avastin as First-Line Therapy in Patients With Advanced Non-Small Cell Lung Carcinoma (NSCLC)
Conditions: Non-Small Cell Lung Cancer
2 Locations available
- Carboplatin and Bevacizumab for Progressive Breast Cancer Brain Metastases
Conditions: Carcinoma Breast Stage IV - Breast Cancer - Progressive Breast Cancer
3 Locations available
- Preoperative Soy Isoflavone Supplementation in the Prevention of Head and Neck Squamous Carcinoma
Conditions: Squamous Carcinoma
1 Location available
- Seneca Valley Virus-001 in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Fea
Conditions: Adrenocortical Carcinoma - Gastrointestinal Carcinoid Tumor - Kidney Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
16 Locations available
- Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate Cancer
Conditions: Prostate Cancer - Adenocarcinoma of the Prostate - Hormone-resistant Prostate Cancer - Stage IV Prostate Cancer
1 Location available
- A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Patients With Hepa
Conditions: Hepatocellular Carcinoma
19 Locations available
- Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma
2 Locations available
- Paclitaxel, Carboplatin and Cetuximab (PCC) Versus Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Loca
Conditions: Head and Neck Squamous Cell Carcinoma
2 Locations available
- Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers
Conditions: Carcinoma, Squamous Cell of the Head and Neck
25 Locations available
- Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Esophagus - Adenocarcinoma of the Gastroesophageal Junction - Diffuse Adenocarcinoma of the Stomach - Intestinal Adenocarcinoma of the Stomach - Mixed Adenocarcinoma of the Stomach - Recurrent Esophageal Cancer - Recurrent Gastric Ca
1 Location available
- Interleukin 2, Aldesleukin and Entinostat for Kidney Cancer
Conditions: Renal Cell Carcinoma
2 Locations available
- CyberKnife Radiosurgery for Localized Prostatic Carcinoma
Conditions: Prostate Cancer
1 Location available
- RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma
Conditions: Colorectal Cancer
2 Locations available
- Cinacalcet Hydrochloride in Treating Men With Recurrent Prostate Cancer
Conditions: Adenocarcinoma of the Prostate - Recurrent Prostate Cancer
1 Location available
- Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colore
Conditions: Carcinoma
1 Location available
- Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck
Conditions: Carcinoma, Adenoid Cystic - Head and Neck Neoplasms
1 Location available
- Trial of BIBW 2992 (Afatinib) + Cetuximab in Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
4 Locations available
- Genistein in Treating Patients With Prostate Cancer
Conditions: Adenocarcinoma of the Prostate - Recurrent Prostate Cancer - Stage I Prostate Cancer - Stage II Prostate Cancer - Stage III Prostate Cancer
1 Location available
- Cetuximab and Lenalidomide in Head and Neck
Conditions: Squamous Cell Carcinoma
1 Location available
- A Study of E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Pri
Conditions: Metastatic Renal Cell Carcinoma
5 Locations available
- Safety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver Transplantation
Conditions: Liver Cirrhosis - Hepatocellular Carcinoma - Liver Transplantation
1 Location available
- Pazopanib Hydrochloride Before Surgery in Treating Patients With Kidney Cancer
Conditions: Clear Cell Renal Cell Carcinoma - Stage I Renal Cell Cancer - Stage II Renal Cell Cancer - Stage III Renal Cell Cancer
3 Locations available
- A Study of Pemetrexed & Carboplatin/Cisplatin or Gemcitabine & Carboplatin/Cisplatin With or Without IMC-1121B in Patients Previously Untreate
Conditions: Carcinoma, Non-Small-Cell Lung
51 Locations available
- Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms
Conditions: Ductal Carcinoma in Situ - Estrogen Receptor-positive Breast Cancer - Progesterone Receptor-positive Breast Cancer - Stage I Breast Cancer - Stage II Breast Cancer - Stage IIIA Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer
1 Location available
- Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma
Conditions: Mouth Neoplasms - Head and Neck Neoplasms - Tongue Neoplasms - Carcinoma, Squamous Cell
2 Locations available
- Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer
134 Locations available
- Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in Surgery
Conditions: Mucinous Adenocarcinoma of the Rectum - Stage IIA Rectal Cancer - Stage IIB Rectal Cancer - Stage IIC Rectal Cancer - Stage IIIB Rectal Cancer - Stage IIIC Rectal Cancer
1 Location available
- Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low- or Intermediate-Grade Neuroendocrine Cancer
Conditions: Extra-Adrenal Paraganglioma - Gastrointestinal Carcinoid Tumor - Head and Neck Cancer - Islet Cell Tumor - Lung Cancer - Neuroendocrine Carcinoma of the Skin - Pheochromocytoma
1 Location available
- Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy
Conditions: Lung Cancer - Non Small Cell Lung Carcinoma - Hypermethylation
1 Location available
- First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
Conditions: Transitional Cell Carcinoma - Bladder Carcinoma - Urothelial Carcinoma
7 Locations available
- Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer
Conditions: BRCA1 Mutation Carrier - BRCA2 Mutation Carrier - Ductal Breast Carcinoma in Situ - Lobular Breast Carcinoma in Situ - Stage IA Breast Cancer - Stage IB Breast Cancer - Stage II Breast Cancer - Stage IIIA Breast Cancer - Stage IIIB Breast Cancer
1 Location available
- A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Re
Conditions: Thymoma - Thymic Carcinoma
2 Locations available
- A First in Man Study to Determine the Safety at Various Dose Levels of AGS-16M8F in Advanced Kidney Cancer
Conditions: Renal Cell Carcinoma - Pharmacokinetics of AGS-16M8F
3 Locations available
- Intensity-Modulated External Beam Radiation Therapy in Treating Patients With Prostate Cancer
Conditions: Adenocarcinoma of the Prostate - Stage I Prostate Cancer - Stage II Prostate Cancer - Stage III Prostate Cancer - Stage IV Prostate Cancer
2 Locations available
- Randomized Study in Locally Advanced Squamous Cell Carcinoma of Head and Neck
Conditions: Head and Neck Cancer
1 Location available
|